Skip to main content

Table 2 The results of univariate and multivariate analysis about α-HBDH on cancer-specific survival

From: Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy

Groups

Cancer-specific survival

Univariate

Multivariate

HR (95%CI), P

HR (95%CI), P

All UTUC patients

 α-HBDH-low group

Reference

Reference

 α-HBDH-high group

1.53 (1.13, 2.07) 0.006

1.36 (1.08, 1.80) 0.034

Patients with pT ≤ 2

 α-HBDH-low group

Reference

Reference

 α-HBDH-high group

1.92 (1.05, 3.51) 0.033

2.04 (1.11, 3.74) 0.021

Patients with pT > 2

 α-HBDH-low group

Reference

Reference

 α-HBDH-high group

1.41 (0.99, 2.01) 0.059

1.00 (0.62, 1.61) 0.994

  1. The detailed results of univariate and multivariate analysis were shown in the supplementary files. Variables included in multivariate analysis were extracted from variables with P value of less than 0.1 in univariate analysis
  2. Abbreviations: HR Hazard ratio, CI Confidence interval, α-HBDH α-hydroxybutyrate dehydrogenase, UTUC Upper tract urothelial carcinoma
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us